# Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost

> **NCT04006561** · — · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Primary CNS Lymphoma
- Brain Lymphoma

## Interventions

- **RADIATION:** A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy

## Key facts

- **NCT ID:** NCT04006561
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2029-02-18
- **Final completion:** 2029-02-18
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04006561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04006561, "Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04006561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*